震裕科技称人形机器人产品逐步推进,要靠工艺优化和规模化降本

林越2026-10-211279人形机器人

南财智讯10月21日电,震裕科技在互动平台表示,公司人形机器人产品工作正逐步推进,后续公司拟通过优化工艺流程、提升产线自动化水平及发挥规模化效应等方式持续推进降本增效。这条消息本身信息量不大,一句逐步推进,一句降本增效,是上市公司互动平台回复的标准措辞。但它出现在这个时间点,和前面讨论的特斯拉第三代Optimus做好量产准备、人形机器人产业链预期升温,可以对得上。

South Finance News, October 21 — Zhenyu Technology stated on its interactive platform that the company's humanoid robot product work is gradually advancing, and the company plans to continuously promote cost reduction and efficiency improvement through optimizing process flows, improving production line automation, and leveraging scale effects. This news itself carries limited information—one sentence on gradual advancement, one on cost reduction and efficiency improvement—standard wording for listed company interactive platform replies. But its appearance at this time aligns with the previously discussed Tesla Gen 3 Optimus ready for mass production and humanoid robot supply chain expectations warming.

 

震裕科技这家公司,做的是精密结构件和电机铁芯,主要客户在汽车、家电、工业领域。人形机器人对精密结构件的需求,和它在汽车、家电领域的积累有技术共通之处。前面讨论过祥鑫科技做汽车座椅骨架,切入机器人灵巧手;也讨论过雷赛智能进入80%以上人形机器人整机厂家供应体系;还讨论过巨蟹智能做关节模组七大核心零部件全自研。震裕科技和这几家的路径类似,都是从原有制造业务向机器人零部件延伸,靠的是精密制造能力的复用。

 

Zhenyu Technology makes precision structural parts and motor cores, with main customers in automotive, home appliance, and industrial fields. Humanoid robots' demand for precision structural parts shares technical commonality with its automotive and appliance accumulation. Earlier we discussed Xiangxin Technology making automotive seat frames and entering robot dexterous hands; Leisai Intelligence entering over 80% of humanoid robot complete machine manufacturers' supply systems; and Juxie Intelligent doing full in-house development of seven core joint module components. Zhenyu Technology follows a similar path to these companies—extending from original manufacturing business to robot components, relying on reuse of precision manufacturing capabilities.

 

它提到的降本增效方式,优化工艺流程、提升产线自动化水平、发挥规模化效应,这三条和前面讨论的微亿智造招股书里提到的成本控制、法奥机器人融资用途里的产能固投、星尘智能提到的量产摊薄制造成本,是同一个逻辑。人形机器人零部件企业现阶段面临的核心问题,不是能不能做出来,而是能不能便宜地、稳定地、大规模地做出来。震裕科技这三条降本路径,工艺优化对应制造环节的效率提升,产线自动化对应人工成本的下降,规模化效应对应固定成本的摊薄。这三条能不能真正兑现,取决于人形机器人整机的出货量能不能起来。前面讨论过工信部上半年人形机器人整机产品超400款、全年产量有望破10万台,也讨论过特斯拉第三代Optimus做好量产准备。整机放量,零部件企业才有规模化效应可言。

 

The cost reduction methods it mentions—optimizing process flows, improving production line automation, and leveraging scale effects—follow the same logic as the previously discussed Micro Intelligence prospectus cost control, Fa'ao Robotics financing use for capacity fixed investment, and Astribot's mention of mass production amortizing manufacturing costs. The core problem humanoid robot component enterprises face at this stage is not whether they can make products but whether they can make them cheaply, stably, and at scale. Zhenyu Technology's three cost reduction paths—process optimization for manufacturing efficiency, production line automation for labor cost reduction, and scale effects for fixed cost amortization—whether these three can truly materialize depends on whether humanoid robot complete machine shipments can rise. Earlier we discussed MIIT's first-half humanoid robot complete machine products exceeding 400 models with full-year output expected to break 100,000 units, and Tesla Gen 3 Optimus ready for mass production. Only when complete machines scale do component enterprises have scale effects to speak of.